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Introduction
Fibromyalgia syndrome (FMS) is a chronic pain condition 
which has a global mean prevalence of 2.7 per cent (Queiroz, 
2013) and has been described as pervading every aspect of 
the individual’s life – occupational, personal, future and 
social (Wuytack and Miller, 2011). Patients frequently also 
experience sleep disturbance, fatigue and psychological dis-
tress, limiting the person’s capacity to work and often dam-
aging their relationships with loved ones. Marcus et al. 
(2013) observed that half of couples, which included one 
person with FMS, were not satisfied with their relationship 
and that their bonds with their children were also affected.
The profound symptomatic impact of FMS may be 
exacerbated by the perceived inauthenticity of the condi-
tion (Lempp et al., 2009). Illness beliefs such as those out-
lined in Leventhal et al.’s (1980) self-regulation model 
(SRM) are a helpful tool to understand the status of an 
illness. Leventhal’s model describes a problem-based 
approach to illness in which our method of coping (and 
subsequent appraisal of this coping strategy) is formu-
lated in response to an interpretation of the illness threat. 
Using this model, we can appreciate how inconsistencies 
in the identity, cause, consequences, timeline and curabil-
ity of FMS might affect the interpretation of FMS and 
subsequently the emotional and coping responses. A ‘dou-
ble burden’ is felt by those whose life is dominated by 
pain as their experience is not adequately acknowledged 
(Juuso et al., 2011). Such contested authenticity in diag-
nosis, treatment and healthcare experience lends to a 
sense of invisibility to the condition and for those living 
with it (Lempp et al., 2009). The recurring theme of dis-
satisfaction in the patient-doctor bond from both perspec-
tives is located in FMS’ uncertainty (Briones-Vozmediano 
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et al., 2013) – without an agreement on aetiology or treat-
ment neither party can successfully engage in the relation-
ship, and frustration may occur.
Attendance at a pain clinic has been shown to reduce 
doctor and clinic utilisation in a retrospective UK analysis 
(Ryan et al., 2012). This underlines the benefit of timely 
referral to a clinic which specialises in managing and treat-
ing known aspects of FMS via a range of potential interven-
tions (not limited to one medical specialism) all from one 
location. A range of treatments and interventions have been 
developed including pharmacological, alternative thera-
pies, psychological, physical activity and interdisciplinary 
programmes. Evidence for the effectiveness of these in 
reducing symptoms is varied and inconsistent. Few inter-
vention trials have measured patient satisfaction, yet there 
is evidence that outcomes sought by the patient and practi-
tioners differ (Mease et al., 2008). In order to develop a 
treatment which will meet patient needs and enjoy long-
term adherence, it is essential to understand the perspec-
tives of the patient – their expectations, their lived 
experience of an intervention, its acceptability, fit with life-
style and their perceptions outcomes and effectiveness 
(O’Brien et al., 2010; Stutts et al., 2009).
A phenomenological approach to the embodied nature 
of illness describes a breakdown of normal existence in 
which our usual lived, pre-reflective body is interrupted by 
consideration of our body as an object of medical observa-
tion (Merleau-Ponty, 2002). This new third-person, medi-
cal gaze observes a biological body which interferes with 
our desires and activities which constitute ‘normal’ life. 
This reconsideration may cause the individual to question 
their own abilities today but may also lead to a yearning for 
the life that has been lost. Chronic illness forces the indi-
vidual and those around them into a reflection on how they 
live, their homes and their relationships (Bhatti et al., 
2011). Qualitative differences in the outlook of those living 
with FMS were described by Mannerkorpi et al. (1999) 
which impact the management and coping styles employed. 
Whether a person is struggling, adapting, in despair or giv-
ing up needs to be not only addressed but also considered in 
a treatment plan.
In this study, we listened to the lived experiences of peo-
ple with FMS with a particular focus on treatments they 
have tried and how these impacted their life. The overall 
aim was to ascertain the effectiveness and adverse reactions 
to treatments with the intention of designing a new inter-
vention within the United Kingdom.
Methods
This qualitative study explored the lived experience of 14 
people with FMS with a particular focus upon treatments 
and interventions they had tried or been offered. The 
rationale of the study led to the utilisation of Interpretative 
Phenomenological Analysis as a theoretical framework 
and analytical method. Interpretative Phenomenological 
Analysis is well-suited to the study of ideographic 
accounts of chronic illness but also as a tool to illuminate 
the connections between participant accounts (Smith 
et al., 1999). Although a literature review had previously 
been undertaken, the themes noted during analysis were 
grounded fully in the data rather than using any a priori 
themes or codes.
Participants
A total of 14 participants were purposefully recruited in the 
South Yorkshire area of the United Kingdom. All partici-
pants had received official medical diagnoses of FMS and 
were over 18 years of age.
The administrators of three FMS support groups were 
contacted in March 2015 and given a full description of the 
research study and asked if they would promote the study to 
their members. Around 30 potential participants made con-
tact with the first author and following further discussions 
and a full briefing, 14 were recruited to the study, and inter-
views took place between May and July 2015.
The participants were all white UK citizens aged 
between 29 and 58 years. All spoke English as their first 
language, and two were men.
Data collection
Ethical approval was obtained prior to data collection from 
the Research Ethics Committee of Sheffield Hallam 
University, and all names and identifiable personal details 
have been anonymised in this article.
The first author conducted in-depth interviews in a pri-
vate location of the participant’s preference – either their 
own home or Sheffield Hallam University. The interviews 
were digitally recorded.
The interviews were semi-structured by the researcher 
with open-ended questions to gain an insight into the psy-
chological and social world of the participant in line with 
the guidance given by Smith (1995); they were informed by 
a review of the existing literature but primarily exploratory 
in keeping with a grounded approach. The participants 
reflected upon their lived experience of FMS and the 
strengths and weaknesses of interventions in terms of per-
ceived symptom relief, user-friendliness, acceptability, life-
style fit and long-term effectiveness while also discussing 
their own needs, expectations and wishes with regard to 
FMS treatments. The interviews lasted between 60 and 
90 minutes and were then transcribed.
Analysis
The interviews were initially read several times by the lead 
author with a focus upon embedding himself within the 
experiences of the participants as far as possible. Three 
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accounts which were particularly rich in data were chosen 
to be interpreted using Interpretative Phenomenological 
Analysis by the lead and second authors. Points of interest 
and significance were noted during the reading of the first 
transcript which progressed during analysis into emergent 
theme titles (or particularly salient phrases) which captured 
the essential quality of the participants account (as far as is 
possible). The emergent themes were noted and clustered 
where appropriate under superordinate themes or salient 
phrases. The three chosen transcripts were analysed in this 
manner individually by both authors who then compared 
their master list of themes and comments. There was 
significant harmony between the analyses during cross- 
validation with several major themes agreed regarding the 
restructuring of social support, ambivalence towards the 
healthcare provided, fighting for help and the status of FMS 
within UK culture. Both authors independently identified 
several significant phrases within the dataset, which seemed 
to describe key aspects of the experience and were subse-
quently incorporated into theme names.
The first author continued analysis of the remaining 11 
accounts as above. The relatively small sample size permit-
ted an iterative process and a close interaction between the 
researcher and the text. Any new emergent themes were 
continually re-checked against the previous accounts to 
ensure a continuity of meaning, and saturation of new 
themes was reached before the analysis was complete.
Results
Six main themes were generated through the analysis of the 
data: Inauthenticity of fibromyalgia, An unconventional 
healthcare experience, Re-creating support networks, 
Challenging the working identity, Threatening the family 
dynamic and Fighting, accepting or accommodating? The 
first theme (Inauthenticity of fibromyalgia) was central, 
and experiences reported under this theme influenced those 
encompassed by the remaining five. The continuing con-
tested status of FMS within the UK National Health Service 
(NHS) and wider society, as perceived by participants, 
formed part (and sometimes the basis) of the tensions 
apparent throughout the remaining five themes.
‘Nothing the doctors couldn’t know …’ – the 
inauthenticity of FMS
Illness representations are governed by an unspoken social 
understanding which is rooted within a traditional, biomed-
ical model of aetiology, diagnosis and treatment plan 
(Leventhal et al., 1980). Lacking clear cause, with diagno-
sis often a complex process and where no established treat-
ment route exists, the authenticity of FMS in particular was 
considered to be contested. One participant described her 
husband commenting that there is ‘nothing the doctors 
couldn’t know’. For her husband, despite witnessing the 
impact of FMS upon his wife for many years, the condition 
still lacked true medical status. Lacking the sense of sup-
port from health professionals, the participant’s search for 
validation can be directed inward, as described here:
I think if I knew why I had it, for me that would probably be 
enough. If somebody says you have this condition because you 
have got this, this, this and this – for me that would be enough 
to know that it’s not my fault because sometimes it feels like 
it’s my fault … it’s got to be something I’ve done.
Alternatively it can be turned outward towards a gen-
eral public who may struggle to comprehend the enormity 
of a condition which does not follow the traditional medi-
cal pathway:
I think they [the public] sort of know what you’re saying but 
don’t think it’s enough to have … the concern over it. I can’t 
live a normal life and if you try to say that to people, they don’t 
understand cos they look at you and think, ‘You’re alright’.
A lack of public understanding about the cyclical nature 
of fibromyalgia, characterised by alternating flare-ups 
(temporary increases in symptoms) and periods of increased 
physical mobility, led to a feeling in nearly half the partici-
pants that FMS was stigmatised: that others perceived their 
condition as an excuse (for laziness or disability benefits) 
or a sign of weakness. Over time, a lack of acknowledge-
ment and public understanding had led to frustration:
Should I walk around with a walking stick … so that you 
leave me alone and you don’t judge me? Should I stay at 
home with me curtains closed and stare at the ceiling just so 
you don’t judge me?
The contested status led to a sense of the invisibility of 
FMS and the minimisation of debilitating symptoms. 
This was a recurring theme throughout the interviews, 
with many explicitly using the word invisibility when 
attempting to describe the internal reality of life with 
FMS: ‘They call it an invisible illness and it really is … 
if you could see how I feel, I would be black and blue’. 
The invisibility of FMS is not a new concept: the term 
has been used in many previous qualitative studies, 
including Sim and Madden’s (2008) review of the FMS 
literature, and by FMS participants themselves, to refer to 
the lack of outward manifestation of the condition. The 
misunderstanding created by the mismatch between the 
inner experience and outward appearance could some-
times extend to the participant’s own experiences and 
expectation of themselves. For example, one participant 
remarked, ‘It being an invisible illness … even to your-
self, sometimes you don’t grasp the idea that you can’t do 
that!’ The fact that their FMS was often co-morbid with 
irritable bowel syndrome (IBS), musculoskeletal issues, 
depression and migraines left participants sometimes 
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uncertain about the distinction between symptoms of 
FMS and those of other conditions, further complicating 
the expression of their own FMS and the clarity of their 
interactions with health professionals.
A common experience recounted by these participants 
was frustration caused by the assertion or suggestion that 
the condition is ‘all in your head’. Without a clear biologi-
cal aetiology, doctors may attribute symptoms to psycho-
logical factors, arguably undermining the overwhelming 
physicality of the experience for sufferers and giving rise to 
the sense of inauthenticity described by these participants. 
Such a response may lead to a suspicion of those who pre-
scribe psychological therapies for pain. One of the partici-
pants in this study commented that if ‘all pain does come 
from your head so they’d be saying everybody’d be lying 
that they’re in pain … everybody could control it’. A 
biopsychosocial model may prove more helpful to balance 
consideration of the psychological (e.g. depression) and 
social factors (e.g. changing social networks and isolation), 
as well as the debilitating physical symptoms associated 
with FMS (Ferrari, 2000).
The inability to exercise regularly or at all, depression 
and side effects of certain medications led to an ongoing 
battle with weight gain for most participants. Weight gain 
acts as a threat to self-esteem but could also form part of the 
public misconceptions of and attitudes towards FMS, based 
in an ongoing discourse within UK culture regarding mobil-
ity, obesity and entitlement to benefits or support. This dis-
course and the resulting attitudes were expressed in one 
participant’s experience: ‘[when I] went into [supermar-
ket], one of the assistants saw me in a wheelchair, she went, 
“Yeah, like she needs a wheelchair, she’s just fat.”’
The experience of FMS for these participants was domi-
nated by a perception that the condition is viewed and 
treated as inferior to others or is used to make judgements 
about the individual themselves. In keeping with previous 
accounts, and reflected in Sim and Madden’s (2008) ‘legiti-
macy’ theme, the sense that their condition and experiences 
lacked authenticity seemed to be the product of both nega-
tive social responses from individuals (family, friends and 
strangers) but also a lack of formal social and medical sup-
port and acknowledgement, which would be expected when 
living with a chronic illness
‘I want answers, don’t just cover it up again’ – 
an unconventional healthcare experience
This second theme is related to the Inauthenticity theme 
above but has a narrower focus upon experiences with the 
NHS and health professionals. These participants described 
a significant breakdown in the traditional medical journey 
from diagnosis to treatment. Chronic illness complicated 
this journey; however, there was still an expectation that 
health professionals would take their presented symptoms 
seriously and offer ongoing support in the management of 
symptoms, expectations which were not met for many of 
the participants. Diagnosis for some was a long time com-
ing, and required considerable persistence:
Keep knocking on t’door … don’t stop knocking … because 
like with me, nobody took any bloods, nobody took any tests, 
nobody did anything until seventeenth time or whenever it 
were.
Following diagnosis, support continued to require pro-
active efforts on the part of sufferers: comments included 
‘I’ve had to ask for everything that I’ve had’ and ‘If you’re 
not moaning, then you just get left on shelf and you’re not 
thought of’. Indeed, diagnosis was not always positive: 
some found it could actually hinder future interactions with 
health professionals because of the tendency for any and all 
symptoms to be attributed to FMS. Several reported dis-
missive attitudes, curtailed consultations and a sense of 
futility regarding their healthcare:
You get to the point where … if I pulled a muscle I would 
probably be unwilling to go to the doctors because you know 
they’ll just say … ‘It’s part of your Fibro … you just have to 
deal with it’.
The contested nature of the illness created difficulties in 
the validation of FMS patients’ experiences by their doc-
tors. These participants felt they were being scrutinised or 
mistrusted by health professionals, especially around the 
requirement for and prescription of analgesic medications. 
Consultations were seen as a ‘battle’, ‘a fight’ in which 
patients were ‘seen as though you are a drug addict just 
wanting stronger pain meds’ and that their explanations of 
their symptoms were regarded as ‘faking it’ and ‘making 
stuff up’. This naturally placed strain on their relationships 
with the medical staff. Another unsatisfactory aspect of 
their healthcare lay at the heart of the FMS experience, 
namely, the lack of answers:
I just collapsed on the bathroom floor, I were just crying … it 
were horrible and they gave me morphine, get pain away and 
they send you on your way. It were like, ‘But what’s wrong, 
why … why am I in this pain? I want answers, don’t just cover 
it up again’.
Their lack of understanding was often attributed by par-
ticipants to a deficit in FMS training for doctors; however, 
there was also a perception that there had been some 
improvements in knowledge among more recently quali-
fied doctors: ‘I find it’s the older GPs [General Practitioner] 
that’s not had the training … because we’re acknowledging 
Fibro more now’.
A primary referral from doctor to rheumatologist is a 
standard route in the United Kingdom for people with sus-
pected FMS for diagnosis and initial treatment. The partici-
pants who discussed their experiences with rheumatologists 
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described little improvement from their consultations with 
general practitioners (GPs) – while one met a specialist 
who was knowledgeable and proactive with advice, the 
remainder were left either without satisfactory treatment 
options or had the authenticity of the condition questioned 
again: ‘She as good as said that it was all in my head’ … she 
said … ‘If you found a job you liked more then you might 
be better’.
Despite accounts of having to argue for analgesic medi-
cations, these were the treatment of choice for most doc-
tors. This contrasts with a recent review of FMS and its 
treatment by Borchers and Gershwin (2015), who recom-
mend a ‘multimodal’ approach in which pharmacological 
therapy plays only one part, accompanied by both psycho-
logical and physical therapies, noting that people with FMS 
‘should not be turned into a poly pharmacy’ (p. 130). Within 
this sample, the most commonly attempted treatments and 
interventions (in order) were pregabalin, acupuncture, 
codeine, exercise, amitriptyline, gabapentin, dietary change 
and supplements, hydrotherapy, planning and pacing, psy-
chological therapies and tramadol. Analgesics and anti-
convulsants (such as gabapentin or pregabalin) were 
described as unsatisfactory because they produced debili-
tating side effects and they proved inadequate in relieving 
pain. Side effects commonly included nausea, disorienta-
tion and drowsiness while the benefits for pain relief dimin-
ished over time. Such limitations and impacts were well 
summed up by one participant in describing how a doctor’s 
role was to ‘poison you enough to make life bearable’. The 
use of analgesics was often a self-management process of 
achieving an acceptable level of pain relief while still being 
able to function:
I’m on a 20mcg patch of Buprenorphine … when I went up to 
35, completely pain-free but I was just out of it for three days 
so I’ve got the balance now where I know I can function at this 
level.
Participants expressed fears about analgesic tolerance 
and were actively engaged in avoiding or navigating addic-
tion when living with chronic pain:
I was 35 … 36 when I was diagnosed properly and I thought 
then that, ‘They’re putting me on morphine at this age … 
where do you go from morphine?’ That’s it, that’s the endpoint.
I’ve been advised not to cut it out entirely because it’s codeine-
based and I’ve been on it a long time. It’s not such a good idea 
to cold turkey after all this time.
One other important consideration regarding treatments 
was the difficulty of leaving home and attending clinics. 
This was a considerable problem for three of the partici-
pants with severe symptoms or restricted mobility, who had 
missed treatments. One participant struggled to attend 
meetings with healthcare professionals: ‘I didn’t get there 
because I [was in] too much pain to actually get there … 
then I kept forgetting. I kept forgetting appointments’.
Beyond analgesics, some had physiotherapy; however, 
these participants had negative perceptions of the discom-
fort of the treatment and a lack of knowledge and empathy 
from the practitioners; similar comments were made about 
massage therapy. Apart from yoga and tai-chi (being too 
strenuous), other alternative therapies received almost 
entirely positive endorsements for symptom and mood 
improvement, and a lack of side effects. Aromatherapy, 
meditation, relaxation tapes and hot baths/hot-water bottles 
were commonly used. The only drawbacks to such thera-
pies were sometimes the prohibitive costs and the difficulty 
of finding practitioners who were willing to work with peo-
ple with FMS. A recurring theme was that ‘most of them 
don’t want to do anything because they’re too worried 
about being sued basically’.
Two treatments prescribed via the NHS – acupuncture 
and hydrotherapy – were seen as very effective; however, 
participants complained about their duration: ‘You only get 
… six weeks and that’s it. So where’s the facility for it 
really?’ Several participants continued to access these ser-
vices privately once the NHS treatment finished due to 
their positive results; however, this had a financial impact 
upon them and their families.
Finally, four of the participants had been referred to a 
pain clinic and described it as an incredibly beneficial 
experience. Many of these participants reported fighting for 
pain clinic referral, echoing the battles for medication 
described above. Those who had persisted and been suc-
cessful in gaining a referral described a service which 
offered expertise and support in pain management and vital 
links to other services. The pain clinic was seen as an option 
to bypass obstructive GPs and get advice regarding dietary 
changes, relationship support and many other problems 
associated with the actual lived experience of chronic ill-
ness beyond medication and exercise. The pain clinic repre-
sented the closest approximation available for most 
participants of a specialist centre for FMS. Four of the par-
ticipants independently questioned the absence of such a 
facility for FMS and linked this to the status of the condi-
tion alongside others. The desire was for ‘a one-stop shop’, 
with a range of useful treatments on offer:
[A hydrotherapy pool], CBT for those who want it, 
physiotherapy, a pain clinic doctor, a rheumatologist and the 
support group in with it … you’d need the gym specifically 
for people … not high weights, running machines … .you 
want a gentle walking machine, the steps … and preferably a 
nurse as well that understands fibromyalgia.
The implications of the study of Briones-Vozmediano 
et al. (2013) on FMS management are pertinent for this 
theme yet underline the considerable change that is required 
to achieve equity in healthcare experience for those with 
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FMS. The authors suggest significant modifications are 
required to improve clinical competencies and doctor–
patient relationships in the form of coherent, multidiscipli-
nary strategies, health professional training and nurturing 
improved therapeutic relationships. One positive conclusion 
(from a United Kingdom perspective) is the reference to the 
use of pain clinics within the United Kingdom as offering 
interdisciplinary expertise in pain management. This is 
undoubtedly supported in this study; however, the validation 
received at the pain clinic is often in contrast to other interac-
tions with health professionals.
Differences in medication beliefs and adherence in 
chronic illness were investigated by Horne and Weinman 
(1999), who highlighted the cost–benefit analysis under-
taken by patients when considering and managing medica-
tions and their adverse effects. Decision-making will form 
part of a large-scale survey to follow this study, focused on 
the experience of available FMS treatments.
‘A Fibro-family’ – re-creating your support 
network
Beyond the healthcare experience, the main sources of sup-
port for the participants were family and friends. The 
impact of FMS on friendship group activities was marked, 
and in some cases, FMS had completely restructured the 
support network. One individual described a regular expe-
rience of the participants, ‘I don’t … associate with anyone 
outside. You might as well call it a Fibro-family because 
people just don’t get it’. Chronic illness can force a close 
examination of personal relationships and sometimes this 
was negotiated by some participants by de-emphasising or 
hiding symptoms: ‘You don’t tell people how you feel 
because they actually don’t want to know. They say, ‘How 
are you?’ but nobody actually wants to know how you are’. 
While those who were not judgemental and could accom-
modate FMS continued as close friends, in the end, the bur-
den of illness led to some bonds being broken as ‘the ones 
that can’t cope pull away and you’d lose contact with them’.
The sample for this study was drawn from local support 
groups and the majority of those who were able to regularly 
attend the meetings stressed the key benefits as helping 
with isolation and meeting people who would be able to 
understand especially soon after diagnosis. ‘It was impor-
tant at that stage to meet people. To know that there were 
other people out there … who felt like I did’. The nature of 
the condition and cultural norms regarding membership of 
support groups (Grande et al., 2006) were described by all 
male participants of the study as potential barriers to male 
attendance, however, one described how FMS had forced a 
reassessment after an initial rejection of alcohol support 
groups earlier in his life:
I’m not normally a support group person but alcohol [was] 
something I wanted to leave behind whereas Fibro is something 
that’s there in the future. I can choose to stop alcohol, I can’t 
choose to stop Fibro.
Wuytack and Miller’s (2011) phenomenological study 
of FMS described the pervasive action of FMS on women’s 
lives, and this was apparent in this study. The incomprehen-
sion of those who do not understand led to the breaking of 
bonds and a desire not to share experiences with others. 
Possibly due to the nature of the sample, the benefits of 
peer support were highly apparent and echo the work of 
Sallinen et al. (2011) whose study demonstrated the impor-
tance of such support networks in the reconstruction of 
identity following diagnosis, acceptance of fibromyalgia 
and ongoing coping mechanisms.
There was ambivalence towards online fora and sup-
port groups among participants who had used them previ-
ously, with half describing the positive nature of 24/7 
support and the opportunity to share ideas about treat-
ments; however, the other half described struggling with 
the sometimes aggressive nature of fora and the mixed 
emotions of seeing the deterioration of others with FMS: 
‘I’ve found I get more depressed looking at them, think-
ing, ‘Jesus, am I gonna get that bad?’
Daraz et al. (2011) evaluated the available online informa-
tion resources for people with FMS (from a primarily North 
American perspective) and concluded there was great varia-
tion in the quality available. This was apparent in a lack of 
comprehensive information on most existing websites, while 
higher quality websites often provided information with tech-
nical language inappropriate for the general population. 
Providing accurate and reliable online information not only 
empowers patients to make informed decisions about their 
own health when they might not be comfortable (or able) to 
discuss with health professionals directly (Sillence et al., 
2007) but also can be a resource for other family members 
and the wider public to learn about the condition.
‘Who swiped my Mum?’ – threatening the 
family dynamic
FMS also compromised the functioning of the family. 
Many of the participants relied heavily upon their partners 
and family for day-to-day tasks and as such; their family 
dynamic had changed with one participant remarking, ‘I’ve 
had to change so much over the years … my children have 
had to change so much around me over the years’. Those 
participants who were married often referred to the strain it 
can place on this relationship and those closest to them: 
‘It’s been 30 years but he’ll say things like, “didn’t know I 
were gonna marry a cripple,” he doesn’t mean it nasty …’. 
Participants understood the strain their FMS symptoms 
placed on others, and this awareness caused distress:
Your pain goes up, your stress goes up and it then affects your 
memory and your concentration and how you … feel and it 
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also affects how you are with other people because you can be 
very short-tempered with people and draw back from people 
and then after you’ve been like that, you feel very upset 
because you’ve been like that to people.
Participants struggled to juggle family demands and the 
needs of their condition. For example, although they 
believed it would benefit their symptoms, participants 
found that making even mundane changes to their diet was 
difficult to achieve due to financial constraints or the daily 
reality of family life. One participant described how her 
family ‘get bored and they won’t eat vegetable soups or a 
vegetable stir-fry. They want English dinners, home-made’. 
The physicality of parenting was another challenge, espe-
cially for those with younger children, for whom FMS 
sometimes acted as a barrier between them and their child:
I try not to let things get me down and I try to push meself to 
do stuff with the kids cos I don’t want them missing out … You 
get hit (with fatigue) and it’s so hard … I struggle to look after 
him because I was so tired all the time.
If my kids could hug me that would be great but they hurt.
Participants recognised that the experiences for the child 
of a parent with FMS could also be devastating, from frus-
tration at the loss of the pre-FMS parent they knew, power-
fully expressed by the son of one participant who asked her, 
‘who swiped my Mum?’ to the fragmentation of the family 
unit: ‘My older son moved in with his Dad cos he couldn’t 
handle seeing me deteriorating in the way I was’.
When discussing the onset of FMS, most of the partici-
pants described a traumatic incident later in life; however, a 
few of the participants described particularly problematic 
childhoods, including abusive relationships. Such experi-
ences could dramatically alter the relationships within the 
family across the generations.
It seems to come up again and again and again either domestic 
abuse from a husband or father or mother … basically your 
whole central nervous system’s sensitive … by keep being hit 
again and again?
Many of the participants discussed the hereditary nature 
of FMS and described close relatives who had also had 
chronic pain conditions. For some, this was accompanied 
by fear for their own children’s health and the construction 
of FMS as an ongoing, intergenerational condition within 
their family: ‘My Dad had severe pain and my daughter has 
severe pain and she’s only 12 … she’s already under the 
pain consultant and so it’s coming up …’.
Wuytack and Miller’s (2011) and Marcus et al.’s (2013) 
studies discussed the negative impact of FMS on family 
bonds, and this was supported in this study. Cudney et al. 
(2002) and Liedberg and Henriksson (2002) mention that 
FMS symptoms negatively affect relationships with family 
members, changing family roles and dynamics, sexual rela-
tions and support. The current findings provide detailed 
insights into how and why this occurs, demonstrating the 
day-to-day impact on being able to parent and maintain inti-
mate relationships in the context of FMS. The experience of 
FMS appeared to create negative self-perceptions in these 
participants. These included the sense of being a burden, the 
belief that their having FMS interfered not only with the 
person’s own activities but also those of family members 
and loved ones. Some also felt they were unable to offer the 
necessary level of support and care for children and were 
impacting negatively upon their development as a result.
‘Taking part of my identity away’ – challenging 
the working identity
A focus group study by Arnold et al. (2008) detailed the 
profound impact FMS can have on the identity of an indi-
vidual in not only their social but also their occupational 
function – the presence of FMS changes the way people 
live their lives. The intense and cyclical nature of FMS 
symptoms can make regular work incredibly difficult, and 
this appeared to have had a severe impact on the identity 
and self-esteem of these participants with FMS:
An occupational health consultant … said to me, ‘I don’t think 
you’ll ever be a physio again’. That’s devastating to be told … 
it’s my career you’re playing with here … somebody’s taking 
part of my identity away from me.
I expect being best okay? … I’m a perfectionist and there is no 
way I’m weak and if I tell people I can’t do things, then I don’t see 
myself as being useful anymore … people come to me for help.
Work was absolutely impossible for many of the partici-
pants and for the others, symptoms and medications dic-
tated the extent to which regular work was possible. This 
created reliance on others, financial difficulties and guilt of 
not being able to provide for their family:
It was my responsibility that was what I was to do and then 
now I … I … [exhales] … no, there’s not a chance on earth. 
There’s some days where I’ll look at me husband and then I 
went, ‘I’m so sorry …’ and I feel … the guilt is horrendous.
The financial reality for many was the need to accept 
benefits but this damaged the pride of those used to work-
ing. A participant described it as ‘soul destroying … I hate 
being on benefits’.
The invisibility of the condition and an ongoing public 
discourse in the United Kingdom regarding the credibility 
of disability benefits can lead to stigmatisation of those 
with FMS. Garthwaite (2011) describes how media lan-
guage can be employed to stigmatise those who receive 
sickness-related benefits as unwilling rather than unable to 
find appropriate work. Such rhetoric from the media and 
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politicians not only fuels public misunderstanding but also 
may reduce the openness of employers to people with dis-
abilities. One participant felt as if society saw them as ‘a 
scrounger. I should get to work … if you’re in a wheelchair 
you got sympathy but if they can’t see your condition they 
won’t believe there’s anything wrong’.
For the employed participants, the ability to continue 
working had become harder, not only due to increasing 
symptoms but also due to the increasing dependence upon 
co-workers’ and employers’ understanding:
I’m not going to be able to work in the true sense of a 9-5 or 
even guarantee I can work set hours … unless I can get a really 
understanding (employer) which I’ve got currently.
These findings are in line with the study of Bossema 
et al. (2012) regarding those sorts of work environments 
those with FMS consider suited to their needs. The par-
ticipants described needing work which is paced in such 
a way so that energy may also be conserved for time 
away from work.
‘The more I push, the more it fights back’ – 
fighting, accepting or accommodating?
The relationship between these participants and their FMS 
developed over time with changes to both the status of the 
condition and the individual. A discord between body and 
mind was alluded to by several of the participants. FMS 
was described as being in control like ‘another person 
strapped to your side that restricts and controls you’ and 
‘It’s almost like my body shuts me down’. The difficulty 
that many participants had in pacing activities to minimise 
the likelihood of flare-ups was based upon a feeling that 
they had to make the most of times when the symptoms 
were less intense. This natural reaction characterised the 
daily experience as an ongoing fight with FMS in order to 
maintain some form of agency. The lived reality of this 
fight is illustrated by extracts from two participants: ‘The 
more you let it, the more it takes’ and ‘the more I push, the 
more it fights back’. It seemed an unwinnable fight, which 
understandably led some to grieve the life they were meant 
to have and feel a profound sense of unfairness in their 
position:
Who gave me this body? I didn’t ask for this one.
Shut the curtains, shut the world out … you have a pity on 
yourself because you think, ‘Why am I dealing with this?…
Where’s my twenties gone because it was such a happy time.
For those further along the illness trajectory, the concept 
of acceptance was occasionally raised:
I think the biggest part of it was acceptance and … I only 
accepted it last year. So what … seven years fighting? … I 
don’t feel disabled, I don’t want to accept that. Eventually 
accepted it over the last year … to tell the truth it hasn’t 
changed things that much that I thought it would.
Although the term ‘acceptance’ was used by partici-
pants, these discussions were centred on the need for 
time and distance to re-build confidence, accept new 
limitations and re-design life around FMS. Thus, the 
notions of adaptation or accommodation were perhaps 
more appropriate to these participants’ experience than 
acceptance, similarly to ‘adapting’ in Mannerkorpi 
et al.’s (1999) ‘patterns of living’ typology. The process 
of gradually accommodating to FMS often took the 
form of major adaptations to lifestyle with some adapt-
ing their home (including converting rooms downstairs), 
two needing crutches or walk-sticks and four using a 
wheelchair. The use of a wheelchair or scooter is often a 
highly emotive and divisive moment for individuals as 
‘it’s like you’ve conceded. It’s like you’ve given up, but 
then what is sitting at home in a chair cos you can’t go 
anywhere … that is conceding as well isn’t it?’
Three of the participants had clearly experienced times 
when acceptance was far from their minds: the hopeless-
ness and burden of the excruciating symptoms and psycho-
social strain had led to thoughts of suicide.
I’d wrote my letters, I’d done everything, I’d took my son to 
where I thought he was safe. Everything had just … nothing 
mattered.
I attempted suicide … It’s just going to get worse and worse 
and worse and living with that feeling and the knowledge that 
there’s nothing I can do that makes it better … there are no 
medications out there that’s going to take this pain away … the 
only way I can’t be like this is to be dead.
Despite occasional accounts of a deep sense of hopeless-
ness, the interviews were characterised – in the gestures 
and the tones used – by pragmatism in the face of many of 
the barriers and difficulties these participants had faced. In 
the end, it seemed one had to persevere and take control of 
the situation oneself because support was often not availa-
ble and even when it was ‘people could give you advice but 
you don’t have to accept it … again it comes down to your 
own personal choice of what you do with the tools availa-
ble (author’s italics) to you’.
Sim and Madden’s (2008) metasynthesis of FMS stud-
ies describes a dualism in the experience of pain which 
was also apparent within this study. While the experi-
enced pain (and FMS generally) was often referred to as 
separate and uncontrollable (using a biomedical model 
which reduces the accountability of the person with 
FMS), participants also referred to the interconnected-
ness of the mind, body and environment in symptom pro-
gression and management. The Cartesian dualism and 
biomedical model are thus enlisted and then rejected in 
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these complex and ambiguous and conflicting under-
standings of the FMS experience.
Discussion
This study demonstrated the immense disruption FMS had 
upon the lives of these participants, the challenges faced in 
accessing treatments and the inadequacy of many treat-
ments. Pain and fatigue seemed at times to dominate their 
lives. Pain was extreme and idiosyncratic but would be 
misunderstood by others largely because of its permanence. 
In keeping with this, Sim and Madden’s (2008) review 
reported that pain was the most commonly described symp-
tom in the qualitative FMS literature, with a recurrent 
theme relating to the difficulties of adequately describing 
the pain experience and having it understood and acknowl-
edged by others. These findings are replicated in more 
recent studies of FMS (Sorensen and Christiansen, 2017) 
and of chronic pain more generally (Stenner et al., 2015), 
with psychosocial impacts attributed to both the pain and 
its incommunicability to and incomprehension by others. In 
our findings, fatigue could be totally debilitating, and the 
personal benefits of activities were constantly balanced 
with their negative consequence. Participants in previous 
studies (e.g. Cudney et al., 2002) have described fatigue as 
the most disabling aspect of the condition, and for many, 
the two symptoms intertwine in that pain is exhausting and 
also interferes with sleep, creating chronic fatigue, with the 
resulting impact on daily activities and relationships (Sim 
and Madden, 2008).
Often for the first time in the participants’ lives, their 
body had become discordant with not only their own inten-
tions but also the social and physical world around them. 
Two themes outlined in Crowe et al.’s (2017) review of 
chronic pain studies, termed ‘body as obstacle’ and ‘dis-
rupted sense of self’, which describe how bodily symptoms 
interfere with lifestyle and identity, have resonance with 
our themes describing changes to participants’ family roles 
and working identity. Frustration and depression are com-
monly described consequences of these disruption of activ-
ities, goals and aspirations in previous work (e.g. Cudney 
et al., 2002; Dow et al., 2012), as they were here.
As described by Merleau-Ponty (2002), chronic illness 
can limit a person’s ability to function and thus redesigns 
their sense of self. Changes to mobility alters the person’s 
way of being in the world while their subjective embodied 
experience takes place within a social world now inhabited 
by health professionals and changed relationships with oth-
ers. Carel (2014), however, asserts the ability of individuals 
to set fluctuating levels of illness to one side, in order to 
carry on as the pain recedes despite the knowledge that the 
symptoms will flare-up again. In this way, consequences 
were usually ignored by the participants of this study in 
order to make the most of the better times. Thus, most par-
ticipants still seemed to be fighting FMS, and others were 
starting to accommodate it in their lives, but few were even 
considering accepting it. Many had been forced to with-
draw from work and from large parts of their social and 
family life as previously observed by Wuytack and Miller 
(2011). Women with FMS described in Liedberg and 
Henriksson’s (2002) study how work offered a source of 
value, structure, fulfilment, and income but added to their 
burden and stress, and increased symptoms of pain and 
fatigue. Most wanted to stay in work but described struc-
tural barriers and interpersonal challenges in so doing, and 
those who had been forced to leave did so reluctantly and 
grieved the losses this created. Similarly, our participants 
had resented and railed against, rather than accepted, these 
enforced changes in their lives.
Opportunities to continue employment may well be con-
trolled by issues outside the individuals control such as the 
need for adjustments to workload, hours and tasks. These 
accommodations require the help and understanding from 
management and colleagues and although complex, this 
study is helpful in re-directing the question of employment 
for people with FMS away from a focus on individual dis-
ability to a consideration of how organisations might sup-
port the desire to continue work. Such thinking is based 
upon a social model of disability (Oliver, 1990) in which 
environmental and social conditions constrain the individu-
al’s opportunity to participate in work and society, and 
which recognises the need for society to change to meet all 
citizen’s needs, rather than requiring individuals to adapt as 
best they can to the status quo.
The chosen method produced rich data which has offered 
insights into the experience of FMS, which both support and 
extend previous findings. They also present a novel and help-
ful view of treatment experiences within the United 
Kingdom, which will be expanded upon in large-scale sur-
veys. Although many of the interviews touched upon emo-
tional and painful experiences, the participants described the 
study experience as useful and were extremely positive that 
their voices were heard and were included in research. A 
common perception was that FMS research (especially in the 
United Kingdom) was lacking, which was seen as further 
evidence of the diminished position of FMS relative to other 
conditions. The sample were drawn from local support 
groups, so these may be individuals who do not perceive 
they are receiving sufficient care from their family and 
healthcare providers, and in some cases, the participants 
were active in attempting to create the expertise and support 
service within their group that they felt was lacking. Many 
from the group were unable to work and so the sample may 
suffer more severe symptoms than the general FMS popula-
tion. Furthermore, the participants had the confidence to par-
ticipate in such a group so may be a more vocal, unsatisfied 
and symptomatic sample than the broader UK population 
with FMS. It may be argued that the issue of authenticity 
itself is a product of a sample of whose search for recognition 
of their illness meant they were more likely to participate.
10 Health Psychology Open 
The issue of the invisibility of the illness was keenly felt 
in this study, similarly to findings made by Lempp et al. 
(2009) and reported in the study of Sim and Madden (2008). 
The incongruity between what is felt by the individual and 
seen by the outsider forms one part of the common thread 
tying the accounts together – that of the authenticity of 
FMS within UK culture. The participants in this study 
shouldered the ‘double burden’ described by Juuso et al. 
(2011) in their experiences with doctors, (ex) friends, fam-
ily and the general public.
Difficulties in doctor–patient relationships often began 
during the long wait for diagnosis, as reported elsewhere. 
For example, Söderberg et al. (1999) captured the lack of 
clarity pre-diagnosis, the initial positivity of diagnosis and 
dissatisfaction with treatment. Accurate diagnosis is impor-
tant; however, the doctor–patient relationship is a long and 
potentially problematic one, especially in the context of 
under-developed understanding of the condition, varied 
treatment paths, many of which prove unsatisfactory, and 
financial constraints on providing more popular options. 
Our study highlights how these aspects contributed to a 
long-term disruption to the expected healthcare experience, 
resulting in growing mistrust of the medical profession, 
indeed, a mutual loss of trust (Juuso et al., 2011). For the 
person with FMS, diagnosis is a step in a process of discov-
ery about the condition and living with it, which gradually 
unfolds and is never complete (Adamson, 1997). Navigating 
this process involves drawing on a range of resources, in 
which medical advice plays a vital, but not by any means 
the only, part (Madden and Sim, 2006).
Participants in this study perceived a lack of expertise 
and resource within the NHS which forced many into dif-
ficult decisions regarding private healthcare. The sense that 
for many patients the onus was upon them to repeatedly 
demand satisfactory treatment for such a debilitating condi-
tion was profound and suggests professionals could con-
sider taking a more proactive approach to FMS. The notion 
of availability of resources referred to in the final data 
extract above – and presented in author’s italics – reflected 
the pragmatic notion that a patient is obliged to take respon-
sibility for their own well-being in the current unsatisfac-
tory state of affairs. The authors suggest that researching 
treatments, with the concomitant energy and skills required 
to access or to demand them, should not be the responsibil-
ity of a patient with a diagnosis of FMS.
Our participants were all drawn from online support groups 
and had, therefore, taken it upon themselves to seek out the 
support they lacked elsewhere. Sim and Madden’s (2008) 
review describes a theme in the literature, ‘Re-evaluation of 
life’, which includes the strain placed by FMS, its impact and 
misunderstandings, on social relationships, resulting relation-
ship breakdown, loneliness and isolation. Raymond and 
Brown (2000) discussed the importance of support groups in 
coping with diagnosis, and Madden and Sim (2006) described 
the role of the support group as an ongoing co-creator of FM 
diagnosis. Interesting in our findings was the notion that peo-
ple would gradually and deliberately loosen ties with people in 
their social network who had been unable to support or vali-
date them and replace these with a ‘Fibro-family’. Somewhat 
in contrast to certain previous findings (e.g. Crowe et al., 
2017; Sorensen and Christiansen, 2017), which suggested that 
people were primarily motivated to maintain existing lifestyles 
and relationships, our data pointed to a movement in some 
participants to, instead, reformulate their lives, support net-
works and roles around fibromyalgia. The data suggested that 
an important part of new relationships was the sense of under-
standing and validation which was lacking elsewhere. These 
new ties suggest the gradual assumption of a new ‘Fibro’ iden-
tity, following disruption and damage to the previous ones, 
rewarded by a sense of ‘belonging’ (Juuso et al., 2013), and 
the positive, affirming experience of offering support to others 
(Schwartz and Sendor, 1999).
Using Leventhal et al.’s (1980) framework for illness 
representations, differences in the socio-cultural setting of 
an illness are expected to have a bearing upon the individ-
ual experience of that illness. In a recent study by Ruiz-
Montero et al. (2015), subtle cultural differences were 
described in the experiences of women with FMS in Spain 
and the Netherlands in terms of illness perception, under-
standing and impact. Kool et al. (2009) considered that 
invalidation of FMS was a combination of the responses of 
family, colleagues and the healthcare system to FMS. Such 
findings underline the very social nature of this phenome-
non and the multiple layers involved in the construction of 
illness authenticity.
The contested status of the condition has led to a social 
construction of FMS which negatively impacts the experi-
ence of those living with it (Lempp et al., 2009). The 
reframing of FMS would require both validation of the con-
dition by health professionals and increased public aware-
ness. Improving the experience for people with FMS by 
challenging issues of illness status is a monumental societal 
task; however, the lived experience of FMS could be 
improved by a proactive health service which acknowl-
edges FMS and improves access to interventions which can 
alleviate symptoms. Acknowledging FMS means admitting 
the shortcomings of medical knowledge (Werner and 
Malterud, 2005), accepting and valuing the experiences and 
expertise of people with FMS (Donaldson, 2009), and sup-
porting and empowering them (Kool et al., 2009). As 
Söderberg et al.’s (1999) participants reported, a simple, 
achievable feature of positive doctor–patient encounters is 
simply being listened to and trusted. Improving access 
ranges from signposting available treatments to research 
and funding to enhance what is currently available. 
Research into improved (or the creation of new) online 
resources which better balance accessibility with content 
may also be of benefit. Currently available interventions 
which could benefit people with FMS – as described by 
these participants – are clearly not being made available to 
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patients or are only accessed by those who have the skills 
and energy available to fight for them, which places many 
people with FMS at a distinct disadvantage. The findings of 
this study are being used inform a national survey to quan-
tify the experience, perceived effectiveness and adverse 
reactions to treatments currently available, with the inten-
tion of designing a new user-focused intervention.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect 
to the research, authorship and/or publication of this article.
Funding
The author(s) disclosed receipt of the following financial support 
for the research, authorship, and/or publication of this article: The 
authors acknowledge the PSP Small Research Grants, Sheffield 
Hallam University for providing financial support for this research.
References
Adamson C (1997) Existential and clinical uncertainty in the med-
ical encounter: An idiographic account of an illness trajec-
tory defined by Inflammatory Bowel Disease and Avascular 
Necrosis. Sociology of Health & Illness 19(2): 133–160.
Arnold LM, Crofford LJ, Mease PJ, et al. (2008) Patient perspec-
tives on the impact of fibromyalgia. Patient Education and 
Counseling 73(1): 114–120.
Bhatti Z, Salek M and Finlay A (2011) Chronic diseases influ-
ence major life changing decisions: A new domain in qual-
ity of life research. Journal of the Royal Society of Medicine 
104(6): 241–250.
Borchers AT and Gershwin ME (2015) Fibromyalgia: A critical 
and comprehensive review. Clinical Reviews in Allergy & 
Immunology 49: 100–151.
Bossema E, Kool M, Cornet D, et al. (2012) Characteristics of 
suitable work from the perspective of patients with fibromy-
algia. Rheumatology 51(2): 311–318.
Briones-Vozmediano E, Vives-Cases C, Ronda-Pérez E, et al. 
(2013) Patients’ and professionals’ views on managing fibro-
myalgia. Pain Research & Management: The Journal of the 
Canadian Pain Society 18(1): 19–24.
Carel H (2014) Ill, but well: A phenomenology of well-being in 
chronic illness. In: Bickenbach JE, Felder F and Schmitz 
B (eds) Disability and the Good Human Life. New York: 
Cambridge University Press, pp. 243–270.
Crowe M, Whitehead L, Seaton P, et al. (2017) Qualitative meta-
synthesis: The experience of chronic pain across conditions. 
Journal of Advanced Nursing 73(5): 1004–1016.
Cudney S, Butler M, Weinert C, et al. (2002) Ten rural women 
living with fibromyalgia tell it like it is. Holistic Nursing 
Practice 16(3): 35–45.
Daraz L, MacDermid J, Wilkins S, et al. (2011) The quality of web-
sites addressing fibromyalgia: An assessment of quality and 
readability using standardised tools. BMJ Open 1(1): 1–7.
Donaldson L (2009) Expert patients usher in a new era of oppor-
tunity for the NHS. BMJ 326: 1279.
Dow CM, Roche PA and Ziebland S (2012) Talk of frustration in 
the narratives of people with chronic pain. Chronic Illness 
8(3): 176–191.
Ferrari R (2000) The biopsychosocial model: A tool for rheuma-
tologists. Baillière’s Clinical Rheumatology 14(4): 787–795.
Garthwaite K (2011) ‘The language of shirkers and scroungers?’ 
Talking about illness, disability and coalition welfare reform. 
Disability & Society 26(3): 369–372.
Grande GE, Myers LB and Sutton SR (2006) How do patients 
who participate in cancer support groups differ from those 
who do not? Psycho-Oncology 15: 321–334.
Horne R and Weinman J (1999) Patients’ beliefs about prescribed 
medicines and their role in adherence to treatment in chronic 
physical illness. Journal of Psychosomatic Research 47(6): 
555–567.
Juuso P, Skär L, Olsson M, et al. (2011) Living with a double 
burden: Meanings of pain for women with fibromyalgia. 
International Journal of Qualitative Studies on Health and 
Well-being 6(3): 7184.
Juuso P, Skär L, Olsson M, et al. (2013) Meanings of feeling 
well for women with Fibromyalgia. Health Care for Women 
International 34: 694–706.
Kool M, Van Middendorp H, Boeije H, et al. (2009) Understanding 
the lack of understanding: Invalidation from the perspective 
of the patient with fibromyalgia. Arthritis Care & Research 
61: 1650–1656.
Lempp HK, Hatch SL, Carville SF, et al. (2009) Patients’ expe-
riences of living with and receiving treatment for fibromy-
algia syndrome: A qualitative study. BMC Musculoskeletal 
Disorders 10: 124.
Leventhal H, Meyer D and Nerenz D (1980) The common 
sense representation of illness danger. In: Rachman S (ed.) 
Contributions to Medical Psychology. Oxford: Pergamon 
Press, pp. 7–30.
Liedberg G and Henriksson C (2002) Factors of importance for 
work disability in women with fibromyalgia: An interview 
study. Arthritis Care & Research 47(3): 266–274.
Madden S and Sim J (2006) Creating meaning in fibromyalgia 
syndrome. Social Science & Medicine 63(11): 2962–2973.
Mannerkorpi K, Kroksmark T and Ekdahl C (1999) How patients 
with fibromyalgia experience their symptoms in everyday 
life. Physiotherapy Research International 4(2): 110–122.
Marcus DA, Richards KL, Chambers JF, et al. (2013) 
Fibromyalgia family and relationship impact exploratory 
survey. Musculoskeletal Care 11(3): 125–134.
Mease P, Arnold L, Crofford L, et al. (2008) Identifying the clini-
cal domains of fibromyalgia: Contributions from clinician 
and patient Delphi exercises. Arthritis Care & Research 
59(7): 952–960.
Merleau-Ponty M (2002) Phenomenology of Perception. London: 
Routledge Classics.
O’Brien EM, Staud RM, Hassinger AD, et al. (2010) Patient-
centered perspective on treatment outcomes in chronic pain. 
Pain Medicine 11(1): 6–15.
Oliver M (1990) The Politics of Disablement. London: Macmillan 
Education.
Queiroz L (2013) Worldwide epidemiology of fibromyalgia. 
Current Pain and Headache Report 17: 1–6.
Raymond M and Brown J (2000) Experience of fibromyal-
gia: Qualitative study. Canadian Family Physician 46: 
1100–1106.
Ruiz-Montero P, Wilgen J, Segura-Jiménez C, et al. (2015) Illness 
perception and fibromyalgia impact on female patients from 
12 Health Psychology Open 
Spain and the Netherlands: Do cultural differences exist? 
Rheumatology International 35(12): 1985–1993.
Ryan S, Packham JC, Dawes P, et al. (2012) The impact of a 
nurse-led chronic musculoskeletal pain clinic on healthcare 
utilization. Musculoskeletal Care 10(4): 196–201.
Sallinen M, Kukkurainen ML and Peltokallio L (2011) Finally 
heard, believed and accepted: Peer support in the narra-
tives of women with fibromyalgia. Patient Education and 
Counseling 85(2): E126–E130.
Schwartz CE and Sendor RM (1999) Helping others helps one-
self: Response shift effects in peer support. Social Science & 
Medicine 48(11): 1563–1575.
Sillence E, Briggs P, Harris P, et al. (2007) Going online for 
health advice: Changes in usage and trust practices over the 
last five years. Interacting with Computers 19(3): 397–406.
Sim J and Madden S (2008) Illness experience in fibromyalgia 
syndrome: A metasynthesis of qualitative studies. Social 
Science & Medicine 67(1): 57.
Smith JA (1995) Semi-structured interviewing and qualitative 
analysis. In: Smith JA, Harré R and Van Langenhove L (eds) 
Rethinking Methods in Psychology. London: SAGE, pp. 9–26.
Smith JA, Jarman M and Osborne M (1999) Doing interpretative 
phenomenological analysis. In: Murray M and Chamberlain 
K (eds) Qualitative Health Psychology: Theories and 
Methods. London: SAGE, pp. 218–240.
Söderberg S, Lundman B and Norberg A (1999) Struggling 
for dignity: The meaning of women’s experiences of liv-
ing with fibromyalgia. Qualitative Health Research 9(5): 
575–587.
Sorensen K and Christiansen B (2017) Adolescents’ experience 
of chronic persistent pain. Scandinavian Journal of Pain 15: 
106–112.
Stenner P, Cross V, McCrum C, et al. (2015) Self-management 
of chronic low back pain: Four viewpoints from patients 
and healthcare providers. Health Psychology Open 2(2): 
2055102915615337.
Stutts LA, Robinson ME, McCulloch RC, et al. (2009) Patient-
centered outcome criteria for successful treatment of facial pain 
and fibromyalgia. Journal of Orofacial Pain 23(1): 47–53.
Werner A and Malterud K (2005) ‘The pain isn’t as disabling as 
it used to be’: How can the patient experience empowerment 
instead of vulnerability in the consultation? Scandinavian 
Journal of Public Health 33(32): 41–46.
Wuytack F and Miller P (2011) The lived experience of fibro-
myalgia in female patients, a phenomenological study. 
Chiropractic & Manual Therapies 19(1): 22.
